Office of Review Management
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Acting Director Sandra Kweder, MD, succeeds former Acting Director Heidi Jolson, MD, who left the agency to become a consultant Jan. 26. Kweder is the fourth person to fill the position in the last six months; her appointment is temporary, according to FDA. Kweder is deputy director of the Office of Drug Evaluation I